IP Verse

Use Of A Pcv2 Immunogenic Composition For Lessening Clinical Symptoms In Pigs - EP3127551

PATENT ANALYSIS

Patent Details

Grant Date
Jul 29, 2020
Company
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
Oppositions

CEVA SANTE ANIMALE

ELANCO US INC.

LABORATORIOS HIPRA, S.A.

More patents of Boehringer Ingelheim Animal Health Usa Inc.

EP3035958

EP3554536

EP2785374

Want to monitor this patent?

Feel free to send us a message here and we will get back to you